Study on EBUS Needle Cleaning for Lung Cancer Staging
This study is looking at how well different cleaning methods work for needles used during Endobronchial Ultrasound (EBUS) bronchoscopy. EBUS is a procedure where a doctor uses a special scope to look inside your airways and take samples from lymph nodes, often to check for lung cancer. The concern is that tiny cancer cells might stay on the needle after taking one sample and then contaminate the next sample, potentially leading to an incorrect diagnosis. This study will compare the usual cleaning method with an additional cleaning step called "purge cleaning" (flushing the needle into a separate vial). The goal is to see if this extra cleaning reduces contamination without affecting the ability to get a good diagnosis. You might be able to join if you are an adult aged 18 or older, are having an EBUS for suspected lung cancer, and will have samples taken from at least two lymph node areas.
- Study design
- This is an interventional study planning to enroll 204 participants. It will compare two different needle cleaning techniques.
- What's involved
- You would undergo a standard EBUS bronchoscopy procedure. The study will evaluate the cleaning techniques used during this procedure.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your samples will be reviewed for contamination for up to 32 weeks after you join the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Yanglin Guo, MD · PRINCIPAL_INVESTIGATOR · University of Mississippi Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Cytologic ContaminationFrom enrollment to the date of the pathological review report of the specimen taken during diagnostic EBUS sampling for a period of up to 32 weeks post enrollment and randomization in trial for each patient enrolled.
To determine the presence of cytologic contamination following standard practice cleaning techniques